Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v3.21.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Cash flows from operating activities:    
Net loss $ (251,038) $ (9,145)
Total (loss)/gain from discontinued operations, net of income taxes (1,022) 28,449
Loss from continuing operations (250,016) (37,594)
Adjustments to reconcile net loss to net cash (used in) operating activities:    
Depreciation and amortization expense 9,804 6,448
Loss/(gain) on debt extinguishment 75 (284)
Bad debt expense 4 0
Stock-based compensation expense 29,265 1,692
Loss on issuance of Bridge Notes 99,669 0
Issuance costs for derivative liabilities and debt carried at fair value 48,009 0
Amortization of debt discount and issuance costs 1,311 955
(Gain)/loss on equity method investment (793) 878
Loss on disposal of property and equipment 24 0
Gain/(loss) on derivatives 11,162 418
Satellite impairment loss 18,407 0
Changes in operating assets and liabilities:    
Accounts receivable (2,010) 481
Contract assets 1,487 (1,898)
Prepaid expenses, and other current assets (4,428) (137)
Other assets (423) (806)
Accounts payable and accrued liabilities (15) 275
Other current liabilities (2,195) 191
Contract liabilities - current and long-term (1,960) 7,932
Liability for estimated contract losses 1,385 6,344
Other long-term liabilities 2,496 2,595
Cash flows used in operating activities - continuing operations (38,742) (12,510)
Cash flows used in operating activities - discontinued operations 0 (14,894)
Net cash used in operating activities (38,742) (27,404)
Cash flows from investing activities:    
Purchase of property and equipment (532) (157)
Satellite procurement work in process (48,951) (18,092)
Purchase of domain name (7) 0
Cash flows used in investing activities - continuing operations (49,490) (18,249)
Cash flows provided by investing activities - discontinued operations 0 8,410
Net cash used in investing activities (49,490) (9,839)
Cash flows from financing activities:    
Proceeds from recapitalization transaction, net of payment of equity issuance costs 245,222 0
Payments of transaction costs related to sponsor earn-out shares (291) 0
Proceeds from issuance of debt 58,573 3,600
Proceeds from options exercised 100 30
Proceeds from warrants exercised 163 0
Capital lease payments 0 (21)
Debt payments (22,198) 0
Issuance costs for derivative liabilities and debt carried at fair value (6,238) (108)
Cash flows provided by financing activities - continuing operations 275,331 3,501
Cash flows used in financing activities - discontinued operations 0 0
Net cash provided by financing activities 275,331 3,501
Net increase/(decrease) in cash, cash equivalents, and restricted cash 187,099 (33,742)
Cash, cash equivalents, and restricted cash – beginning of year 10,573 37,190
Cash reclassified to assets held for sale at beginning of period 0 11,383
Cash, cash equivalents, and restricted cash – end of period 197,672 14,831
Supplemental Cash Flow Elements [Abstract]    
Cash and cash equivalents 194,942 9,356
Restricted cash 2,730 5,475
Total cash, cash equivalents, and restricted cash 197,672 14,831
Supplemental disclosures of cash flows information:    
Cash paid for interest 398 954
Supplemental disclosures of non-cash financing and investing information:    
Property and equipment additions accrued but not paid 1,184 4,496
Equity costs accrued but not paid 388 0
Capitalized interest 735 1,086
Issuance of common stock due to Bridge Notes and rights offering, net of issuance 106,353 0
Issuance of common stock warrants due to Bridge Notes 18,800 0
Net exercise of common stock warrants 210 0
Conversion of Bridge Notes 77,097 0
Net exercise of Bridge Note warrants 38,329 0
Contingent liability for working capital adjustment to M&Y Space Co. Ltd 1,022 0
Application of Secured Loan against a share purchase agreement purchase price 0 26,182
Equipment acquired under capital lease 0 22
Preferred Stock    
Supplemental disclosures of non-cash financing and investing information:    
Issuance of preferred stock in the sale of Spaceflight, Inc. 0 3,247
Common Stock warrants    
Supplemental disclosures of non-cash financing and investing information:    
Conversion of stock $ 1,324 $ 0